The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division.

MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced ...

Abstract: The time-varying phase-switched screen (PSS) has demonstrated a significant potential for modulating radar target features, due to its exceptional capabilities in the harmonic generation and ...

Abstract: Triple-phase-shift (TPS) modulation endows dual-active-bridge (DAB) DC-DC converters with three independent degrees of freedom, enabling simultaneous control of power flow, device stress, ...

Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia Rilzabrutinib is the first and only investigational BTKi ...

ARC Raiders is giving players who missed out on the first Expedition a great reason to depart on the second one, and it leaves very soon.

The Phase 1 clinical trial, STRIKE-001 (NCT07103018), is a multi-center, open-label dose escalation of KTX-2001 monotherapy (Part A) and in combination with darolutamide, an oral, nonsteroidal ...

Chowning is a composer, musician and professor that had a seismic impact on both the development of music technology and the ...

A wide of array of advanced controllers arrived in 2025, marked by high integration and enhanced intelligence in solutions ...

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

LCGC International salutes Jack Henion and Bob W.J. Pirok, winners of the 19th annual LCGC Lifetime Achievement and Emerging ...